Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: Dependence on the dose of progestin

Annals of Medicine

Volumn 36, Issue 4, 2004, Pages 278-284

  Ahotupa, Markku ^a,f   Rauramo, Ilkka ^b   Vasankari, Tommi J ^c   Skouby, Sven O ^d   Hakonen, Tiina ^e  

^a UNIVERSITY OF TURKU   (Finland)

^b Finska Lo karforeningen Duodecim   (Finland)

^c Sports Medical Research Unit   (Finland)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e Bayer Oy   (Finland)

^f MCA Research Laboratory Ltd   (Finland)

Author keywords

Antioxidant; Atherosclerosis; Estrogen; Hormonal therapy; LDL oxidation; Progestin

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; GESTAGEN; LEVONORGESTREL; NORETHISTERONE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; IN VIVO STUDY; MEASUREMENT; METHODOLOGY; NORMAL HUMAN; OXIDATION; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 2942750540     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890410032820     Document Type: Article

References (34)

1. Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990;9:155-68.
2. Witztum J, Steinberg D. Role of oxidized LDL in atherogenesis. J Clin Invest 1991;88:1785-92.
3. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 1992;13:241-90.
4. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-5.
5. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
6. Steinberg D. Low density lipoprotein oxidation and its pathological significance. Biol Chem 1997;272:20963-55.
7. Ahotupa M, Vasankari T. Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. Free Radic Biol Med 1999;27:1141-50.
8. Grodstein F, Stamfer M. The epidemiology of coronary heart disease and estrogen replacement therapy in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
9. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
10. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
11. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17-beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Biol Med 1990;8:167-73.
12. McManus J, McEneny J, Young IS, Thompson W. The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro. Maturitas 1996;25:125-31.
13. Schroder J, Doren M, Schneider B, Oettel M. Are the antioxidative effects of 17-beta-estradiol modified by concomitant administration of a progestin? Maturitas 1996;25:133-9.
14. Shwaery GT, Vita JA, Keaney JF, Jr. Antioxidant protection of LDL by physiological concentrations of 17-beta-estradiol. Requirement for estradiol modification. Circulation 1997;95:1378-85.
15. Seegar H, Mueck AO, Lippert TH. The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL. Int J Pharmacol Ther 1998;36:383-385.
16. Mueck AO, Seeger H, Lippert TH. Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect? Clin Exp Obstet Gynecol 1998;25:26-8.
17. Sack MN, Rader DJ, Cannon RO 3rd. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
18. Wakatsuki A, Ikenoue N, Sagara Y. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas 1998;28:229-34.
19. Nenseter MS, Volden V, Berg T, Drevon CA, Ose L, Tonstad S. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest 1996;26:1062-8.
20. McManus J, McEneny J, Thompson W, Young IS. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis 1997;135:73-81.
21. Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas 1999;33:259-269.
22. Wen Y, Doyle MC, Norris LA, Sinnott MM, Cooke T, Harrison RF, et al. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol 1999;47:315-21.
23. Hoogerbrugge N, Zillikens MC, Jansen H, Meeter K, Deckers JW, Birkenhager JC. Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease. Metabolism 1998;47:675-80.
24. Heikkinen AM, Niskanen L, Ylä-Herttuala S, Luoma J, Tuppurainen MT, Komulainen M, et al. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. Maturitas 1998;29:155-61.
25. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
26. Devaraj S, Jialal I. Laboratory assessment of lipoprotein oxidation. In: Rifai N, Warnick GRA, Dominiczak M, editors. Handbook of Lipoprotein Testing. Washington DC: AACC Press; 1997:357-73.
27. Ahotupa M, Ruutu M, Mäntylä E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 1996;29:139-44.
28. Vasankari TJ, Kujala U, Vasankari TM, Ahotupa M. Reduced oxidized LDL levels after a ten-month exercise program. Med Sci Sports Exerc 1998;30:1496-1501.
29. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P, et al. Reduced LDL oxidation after weight reduction in obese premenopausal women. Int J Obes Relat Metab Disord 2001;25:205-11.
30. Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men. JAMA 2002;287:598-605.
31. Agarwal S, Rao AV. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998;33:981-4.
32. Subakir SB, Abdul Madjid O, Sabariah S, Affandi B. Oxidative stress, vitamin E and progestin breakthrough bleeding. Hum Reprod 2000;3:18-23.
33. Raudaskoski T, Tapanainen J, Tomas E, Luotola H, Pekonen F, Ronni-Sivula H, et al. Intrauterine 10 μg and 20 μg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response. Br J Obstet Gynaecol 2002;109:136-44.
34. Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women. Circulation 2002;106:1771-6.